Literature DB >> 8021914

Anti-HIV michellamines from Ancistrocladus korupensis.

M R Boyd1, Y F Hallock, J H Cardellina, K P Manfredi, J W Blunt, J B McMahon, R W Buckheit, G Bringmann, M Schäffer, G M Cragg.   

Abstract

Here we report details of the isolation and determination of the absolute configurations and comparative anti-HIV activities of novel, atropisomeric naphthylisoquinoline alkaloid dimers, michellamines A, B, and C, from a newly described species of Ancistrocladus from the Korup rainforest of Cameroon. We further provide a more extensive analysis of the range of anti-HIV activity of michellamine B, the most potent and abundant member of the series. Michellamine B inhibited HIV-induced cell killing and viral replication in a variety of human cell lines, as well as in cultures of human peripheral blood leukocytes and monocytes. Michellamine B was active against a panel of biologically diverse laboratory and clinical strains of HIV-1, including the AZT-resistant strain G910-6 and the pyridinone-resistant strain A17; the compound also inhibited several strains of HIV-2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021914     DOI: 10.1021/jm00038a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

Review 1.  The Challenge of Reproducibility and Accuracy in Nutrition Research: Resources and Pitfalls.

Authors:  Barbara C Sorkin; Adam J Kuszak; John S Williamson; D Craig Hopp; Joseph M Betz
Journal:  Adv Nutr       Date:  2016-03-15       Impact factor: 8.701

2.  Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms.

Authors:  J B McMahon; M J Currens; R J Gulakowski; R W Buckheit; C Lackman-Smith; Y F Hallock; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

3.  Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.

Authors:  Xuemei Yu; Bruno Sainz; Pavel A Petukhov; Susan L Uprichard
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

4.  Evaluation of the antibacterial and anticancer activities of some South African medicinal plants.

Authors:  Mary A Bisi-Johnson; Chikwelu L Obi; Toshio Hattori; Yoshiteru Oshima; Shenwei Li; Learnmore Kambizi; Jacobus N Eloff; Sandeep D Vasaikar
Journal:  BMC Complement Altern Med       Date:  2011-02-17       Impact factor: 3.659

Review 5.  Dimeric Cinchona alkaloids.

Authors:  Przemysław J Boratyński
Journal:  Mol Divers       Date:  2015-01-15       Impact factor: 2.943

6.  De-novo design, synthesis and evaluation of novel 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors.

Authors:  Subhash Chander; Penta Ashok; Anupam Singh; Sankaranarayanan Murugesan
Journal:  Chem Cent J       Date:  2015-06-09       Impact factor: 4.215

Review 7.  Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products.

Authors:  Ramandeep Kaur; Pooja Sharma; Girish K Gupta; Fidele Ntie-Kang; Dinesh Kumar
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

8.  Phytochemical analysis and in-vitro anti-African swine fever virus activity of extracts and fractions of Ancistrocladus uncinatus, Hutch and Dalziel (Ancistrocladaceae).

Authors:  Folorunso O Fasina; Oyinlola O Olaokun; Olusola O Oladipo; Margaret M Fasina; Adesoji A Makinde; Livio Heath; Armanda D S Bastos
Journal:  BMC Vet Res       Date:  2013-06-19       Impact factor: 2.741

9.  Biocatalytic production of tetrahydroisoquinolines.

Authors:  Bettina M Ruff; S Bräse; Sarah E O'Connor
Journal:  Tetrahedron Lett       Date:  2012-02-29       Impact factor: 2.032

10.  Antiplasmodial Ealapasamines A-C,'Mixed' Naphthylisoquinoline Dimers from the Central African Liana Ancistrocladus ealaensis.

Authors:  Dieudonné Tshitenge Tshitenge; Doris Feineis; Virima Mudogo; Marcel Kaiser; Reto Brun; Gerhard Bringmann
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.